The final list of price concessions granted for February 2026 includes 174 lines. This is the highest number of concessions granted since March 2023. Drug price concessions hit three-year high | The Pharmaceutical Journal Our Director of Research and Insights, Dr. James Davies, said: “It has been a very worrying start to 2026 – with
Community pharmacies received strong backing yesterday in Parliament, with several MPs speaking out in support of the sector, recognising their vital role in community healthcare and raising concerns about an increasing trend of pharmacy closures. Discussions during the Parliamentary debate, which focussed on ‘Healthcare in Rural Areas’, emphasised that pharmacies are essential for providing accessible
The following price concessions granted in February 2026 have rolled over to March 2026: Drug Pack size Price concession Quinine sulfate 300mg tablets 28 £2.01 Venlafaxine 37.5mg tablets 56 £2.60 Please note any rolled over prices can be adjusted upwards if we receive reports from pharmacy owners to indicate suppliers’ selling prices have increased. The
The Department of Health and Social Care (DHSC) has today (03/03/2026) confirmed the following final list of price concessions for February 2026: Drug Pack size Price concession Aqueous cream 100 £0.99 Aqueous cream 500 £5.80 Clarithromycin 125mg/5ml oral suspension 70 £11.10 (previously £9.59) Lofepramine 70mg tablets 56 £24.86 (previously £23.89) Trimethoprim 100mg tablets 28 £4.07 (previously
The Department of Health and Social Care (DHSC) has entered consultation with Community Pharmacy England on the 2026/27 Community Pharmacy Contractual Framework (CPCF). A letter signalling the start of the formal negotiations process was sent to Community Pharmacy England this week. Detailed discussions begin immediately and will cover funding, service changes and other arrangements for
The Department of Health and Social Care (DHSC) has today (27/02/2026) confirmed the following list of price concessions for February 2026: Please note: Community Pharmacy England has submitted price concession applications for a number of other medicines affected by pricing issues this month. We will issue further updates as soon as we hear back from the Department.
The Department of Health and Social Care (DHSC) has today (26/02/2026) confirmed the following list of price concessions for February 2026: Please note: Community Pharmacy England has submitted price concession applications for a number of other medicines affected by pricing issues this month. We will issue further updates as soon as we hear back from
Department of Health and Social Care (DHSC) has issued a medicine supply notification for Co-trimoxazole 40mg/200mg/5ml oral suspension sugar free and Co-trimoxazole 80mg/400mg/5ml oral suspension MSN/2026/016 Tier 2 – medium impact Date of issue: 25 February 2026 Co-trimoxazole 40mg/200mg/5ml oral suspension sugar free will be out of stock from mid-March until June 2026. Co-trimoxazole 80mg/400mg/5ml
The reimbursement prices for the first 11 multi-source products moving from Category C to the new Category H have been published in the March 2026 Drug Tariff. Prices for 6 products have increased whereas 5 products have seen a decrease compared to their previous Category C prices. Ursodeoxycholic acid 500mg tablets (100) has the largest
The Drug Tariff Preface published monthly, lists additions, deletions and other changes to products listed in the Drug Tariff. Below is a summary of the changes coming into effect from 1 March 2026. Part VIIIA – Basic prices of drugs Contractors should note changes made to the notes to Part VIIIA regarding Categories A, C, H and M.
